Association Between Outcomes of Bariatric Surgery and Preoperative Gastrointestinal Microbiota
NCT ID: NCT04471077
Last Updated: 2020-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2018-12-01
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Materials and methods Design This prospective cohort study was conducted in one academic, teaching hospital. The recommendations of the Metabolic and Bariatric Surgery Section of the Polish Surgical Society were used as indication for surgery, that is: Body Mass Index (BMI) ≥35 kg/m2 with obesity-related comorbidities or BMI ≥40 kg/m2 .
Analysis and endpoints Primary endpoint was to determine the difference in microbiota present in oral cavity and large intestine between patients ing Group 1 and Group 2. Secondary endpoint was to compare the results of microbiota analysis between LSG and LRYGB.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes of Oral and Intestinal Microbiota After Bariatric Surgery
NCT04582006
Role of the Microbiota in Obesity: Effect After Bariatric Surgery
NCT07277465
Intestinal Microbiota in Patients Before and After Bariatric Surgery and Healthy Controls
NCT02563119
Bariatric Surgery: Microbiome & Diabetes
NCT03723486
Quality of Life 10 Years After Bariatric Surgery
NCT04190459
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Favorable outcome of bariatric surgery
Excess weight loss above 50%
bariatric surgery
(Laparoscopic Sleeve Gastrectomy, laparoscopic Roux-en-Y gastric bypass)
Unfavorable outcome of bariatric surgery
Excess weight loss below 50%
bariatric surgery
(Laparoscopic Sleeve Gastrectomy, laparoscopic Roux-en-Y gastric bypass)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bariatric surgery
(Laparoscopic Sleeve Gastrectomy, laparoscopic Roux-en-Y gastric bypass)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jagiellonian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tomasz Stefura
Reasearch Associate, PhD student at 2nd Department of General Surgery, Principal Investigator, Medical Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
2nd Department of General Surgery, Jagiellonian University Medical College
Krakow, Małopolska, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1072.6120.196.2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.